EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhancing Maturation and Translatability of Human Pluripotent Stem Cell-Derived Cardiomyocytes through a Novel Medium Containing Acetyl-CoA Carboxylase 2 Inhibitor

Cláudia Correia, Jonas Christoffersson iD, Sandra Tejedor iD, Saïd El-Haou, Meztli Matadamas-Guzman iD, Syam Nair, Pierre Dönnes iD, Gentian Musa, Mattias Rohman, Monika Sundqvist, Rebecca B Riddle iD, Bramasta Nugraha iD und 7 weitere

Cells · 13.08.2024 · 13 (16) · 1339

DOI: 10.3390/cells13161339 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 13.08.2024. Verfasst von Cláudia Correia und 18 weiteren Autor:innen. Beteiligte Einrichtung: Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 43150 Gothenburg, Sweden. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Acetyl-CoA Carboxylase, Pluripotent Stem Cells, Cell Differentiation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Knowledge Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) constitute an appealing tool for drug discovery, disease modeling, and cardiotoxicity screening. However, their physiological immaturity, resembling CMs in the late fetal stage, limits their utility. Herein, we have developed a novel, scalable cell culture medium designed to enhance the maturation of hPSC-CMs. This medium facilitates a metabolic shift towards fatty acid utilization and augments mitochondrial function by targeting Acetyl-CoA carboxylase 2 (ACC2) with a specific small molecule inhibitor. Our findings demonstrate that this maturation protocol significantly advances the metabolic, structural, molecular and functional maturity of hPSC-CMs at various stages of differentiation. Furthermore, it enables the creation of cardiac microtissues with superior structural integrity and contractile properties. Notably, hPSC-CMs cultured in this optimized maturation medium display increased accuracy in modeling a hypertrophic cardiac phenotype following acute endothelin-1 induction and show a strong correlation between in vitro and in vivo target engagement in drug screening efforts. This approach holds promise for improving the utility and translatability of hPSC-CMs in cardiac disease modeling and drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacAcetyl-CoA CarboxylasePluripotent Stem CellsCell DifferentiationHumansCulture MediaEnzyme InhibitorsAnimals

Stichwörter der Autor:innen

acetyl-CoA carboxylase 2 (ACC2)cardiac hypertrophyhuman pluripotent stem cell-derived cardiomyocyte (hPSC-CM) maturationin vitro-to-in vivo correlationtranslatable in vitro model

Substanzen

Acetyl-CoA CarboxylaseCulture MediaACACB protein, humanEnzyme Inhibitors

Autor:innen und Institutionen

  • Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 43150 Gothenburg, Sweden.
  • Systems Biology Research Center, School of Bioscience, University of Skövde, 54128 Skövde, Sweden.
  • Mechanistic Biology and Profiling, Discovery Sciences, AstraZeneca R&D, Cambridge CB2 0AA, UK.
  • SciCross AB, 54135 Skövde, Sweden.
  • Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, 43150 Gothenburg, Sweden.
  • Department of Pharmacology, University of Cambridge, Cambridge CB2 1PD, UK.

ORCID-Profile: Jonas Christoffersson, Sandra Tejedor, Meztli Matadamas-Guzman, Pierre Dönnes, Rebecca B Riddle, Bramasta Nugraha, Markus Johansson, Qing-Dong Wang, Karin Jennbacken, Daniela Später

Förderung

  • Swedish Knowledge Foundation

Zitieren

APA

Correia, C., Christoffersson, J., Tejedor, S., El-Haou, S., Matadamas-Guzman, M., Nair, S., Dönnes, P., Musa, G., Rohman, M., Sundqvist, M., Riddle, R. B., Nugraha, B., Bellido, I. S., Johansson, M., Wang, Q. D., Hidalgo, A., Jennbacken, K., Synnergren, J., & Später, D. (2024). Enhancing Maturation and Translatability of Human Pluripotent Stem Cell-Derived Cardiomyocytes through a Novel Medium Containing Acetyl-CoA Carboxylase 2 Inhibitor. Cells, 13(16), 1339. https://doi.org/10.3390/cells13161339

Vancouver

Correia C, Christoffersson J, Tejedor S, El-Haou S, Matadamas-Guzman M, Nair S, et al. Enhancing Maturation and Translatability of Human Pluripotent Stem Cell-Derived Cardiomyocytes through a Novel Medium Containing Acetyl-CoA Carboxylase 2 Inhibitor. Cells. 2024;13(16):1339. doi:10.3390/cells13161339

BibTeX
@article{Correia2024,
  author = {Correia, Cláudia and Christoffersson, Jonas and Tejedor, Sandra and El-Haou, Saïd and Matadamas-Guzman, Meztli and Nair, Syam and Dönnes, Pierre and Musa, Gentian and Rohman, Mattias and Sundqvist, Monika and Riddle, Rebecca B and Nugraha, Bramasta and Bellido, Ioritz Sorzabal and Johansson, Markus and Wang, Qing-Dong and Hidalgo, Alejandro and Jennbacken, Karin and Synnergren, Jane and Später, Daniela},
  title = {Enhancing Maturation and Translatability of Human Pluripotent Stem Cell-Derived Cardiomyocytes through a Novel Medium Containing Acetyl-CoA Carboxylase 2 Inhibitor},
  journal = {Cells},
  year = {2024},
  volume = {13},
  number = {16},
  pages = {1339},
  doi = {10.3390/cells13161339}
}
Kostenlos starten →